| The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair L Dou, E Bertrand, C Cerini, V Faure, J Sampol, R Vanholder, Y Berland, ... Kidney international 65 (2), 442-451, 2004 | 554 | 2004 |
| The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells L Dou, N JOURDE‐CHICHE, V Faure, C Cerini, Y Berland, ... Journal of Thrombosis and Haemostasis 5 (6), 1302-1308, 2007 | 457 | 2007 |
| Elevation of circulating endothelial microparticles in patients with chronic renal failure V Faure, L Dou, F Sabatier, C Cerini, J Sampol, Y Berland, P Brunet, ... Journal of Thrombosis and Haemostasis 4 (3), 566-573, 2006 | 391 | 2006 |
| Endothelium structure and function in kidney health and disease N Jourde-Chiche, F Fakhouri, L Dou, J Bellien, S Burtey, M Frimat, ... Nature Reviews Nephrology 15 (2), 87-108, 2019 | 388 | 2019 |
| The cardiovascular effect of the uremic solute indole-3 acetic acid L Dou, M Sallée, C Cerini, S Poitevin, B Gondouin, N Jourde-Chiche, ... Journal of the American society of nephrology 26 (4), 876-887, 2015 | 299 | 2015 |
| Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway B Gondouin, C Cerini, L Dou, M Sallée, A Duval-Sabatier, A Pletinck, ... Kidney international 84 (4), 733-744, 2013 | 239 | 2013 |
| The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease M Sallée, L Dou, C Cerini, S Poitevin, P Brunet, S Burtey Toxins 6 (3), 934-949, 2014 | 236 | 2014 |
| Vascular incompetence in dialysis patients—protein‐bound uremic toxins and endothelial dysfunction N Jourde‐Chiche, L Dou, C Cerini, F Dignat‐George, P Brunet Seminars in dialysis 24 (3), 327-337, 2011 | 199 | 2011 |
| Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke C Moubarik, B Guillet, B Youssef, JL Codaccioni, MD Piercecchi, ... Stem Cell Reviews and Reports 7, 208-220, 2011 | 193 | 2011 |
| Progress in uremic toxin research: protein‐bound toxins—update 2009 N Jourde‐Chiche, L Dou, C Cerini, F Dignat‐George, R Vanholder, ... Seminars in dialysis 22 (4), 334-339, 2009 | 193 | 2009 |
| Does uremia cause vascular dysfunction P Brunet, B Gondouin, A Duval-Sabatier, L Dou, C Cerini, ... Kidney and blood pressure research 34 (4), 284-290, 2011 | 186 | 2011 |
| Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients N JOURDE‐CHICHE, L Dou, F Sabatier, R Calaf, C Cerini, S Robert, ... Journal of Thrombosis and Haemostasis 7 (9), 1576-1584, 2009 | 130 | 2009 |
| P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines L Dou, C Cerini, P Brunet, C Guilianelli, V Moal, G Grau, R De Smet, ... Kidney international 62 (6), 1999-2009, 2002 | 125 | 2002 |
| Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients V Moal, P Brunet, L Dou, S Morange, J Sampol, Y Berland Nephrology Dialysis Transplantation 18 (9), 1834-1841, 2003 | 112 | 2003 |
| Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro—towards a standardized approach for research on uraemia G Cohen, G Glorieux, P Thornalley, E Schepers, N Meert, J Jankowski, ... Nephrology Dialysis Transplantation 22 (12), 3381-3390, 2007 | 108 | 2007 |
| P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro C Cerini, L Dou, F Anfosso, F Sabatier, V Moal, G Glorieux, R De Smet, ... Thrombosis and haemostasis 92 (07), 140-150, 2004 | 108 | 2004 |
| Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease L Dou, S Poitevin, M Sallée, T Addi, B Gondouin, N McKay, MS Denison, ... Kidney international 93 (4), 986-999, 2018 | 98 | 2018 |
| Tryptophan-derived uremic toxins and thrombosis in chronic kidney disease T Addi, L Dou, S Burtey Toxins 10 (10), 412, 2018 | 79 | 2018 |
| Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels B Gondouin, N Jourde-Chiche, M Sallee, L Dou, C Cerini, A Loundou, ... Nephron 131 (3), 167-174, 2015 | 77 | 2015 |
| Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay R Calaf, C Cerini, C Génovésio, P Verhaeghe, N Jourde-Chiche, ... Journal of Chromatography B 879 (23), 2281-2286, 2011 | 76 | 2011 |
